ESP 2.0

About Emet Surgical

Emet Surgical is pioneering AI-driven surgical intelligence with its ESP platform, designed to act as a 'surgical co-pilot' by providing real-time visual guidance and anomaly detection during procedures. The technology, built on over 20 person-years of licensed university research, is a software-only solution that integrates with existing OR equipment without requiring new hardware, contrast agents, or extensive surgeon training. The company is currently raising a $3M seed round, planning clinical validation studies, and targeting FDA 510(k) clearance by Q2 2027, initially focusing on incidental cancer detection and endometriosis identification.

Therapeutic Areas